Skip to main content

FRONTIER CAPITAL MANAGEMENT CO LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 351173 Boston, MA

Position in CRL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,290,695
-$16,385,180 QoQ
Shares Held
48,062
-61.1% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 76.19116973908702.ToString("F0")% Shared 0.ToString("F0")% None 23.808830260912988.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

FRONTIER CAPITAL MANAGEMENT CO LLC holds $144,741,915 across 8 Diagnostics & Research names. CRL ranks #7 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 CRL
Charles River Laboratories International, Inc.
This page
48,062 $8,290,695

All Filings in CRL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,290,695 48,062
2025-12-31 $24,675,875 123,701
2025-09-30 $7,866,026 50,275
2025-06-30 $7,859,765 51,801
2025-03-31 $10,697,757 71,072
2024-12-31 $13,515,489 73,215
2024-09-30 $14,447,355 73,348
2024-06-30 $15,365,626 74,381
2024-03-31 $18,458,739 68,126
2023-12-31 $12,085,477 51,123
2023-09-30 $9,291,803 47,412
2023-06-30 $5,747,394 27,336
2023-03-31 $5,573,259 27,615
2022-12-31 $6,560,315 30,107